Inner retinal layer thinning in Parkinson disease.
暂无分享,去创建一个
I. Bodis-Wollner | W. March | D. Lazzaro | Douglas R Lazzaro | Arthur H Wolintz | Ivan G Bodis-Wollner | Mohammedyusuf E Hajee | Wayne F March | Eric M Shrier | Sofya Glazman | S. Glazman | E. Shrier | M. Hajee | A. Wolintz
[1] J. Duker,et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. , 2005, Ophthalmology.
[2] J. Katz,et al. Analysis of progressive change in automated visual fields in glaucoma. , 1996, Investigative ophthalmology & visual science.
[3] J Katz,et al. Reliability indexes of automated perimetric tests. , 1988, Archives of ophthalmology.
[4] A. Tzelepi,et al. The Effect of Diverse Dopamine Receptors on Spatial Processing in the Central Retina , 2005 .
[5] James Parkinson,et al. An essay on the shaking palsy. 1817. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[6] M. B. Shields,et al. PREDICTIVE FACTORS FOR GLAUCOMATOUS VISUAL FIELD PROGRESSION IN THE ADVANCED GLAUCOMA INTERVENTION STUDY , 2005 .
[7] J. Fujimoto,et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. , 1996, Ophthalmology.
[8] M. Yahr,et al. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. , 1987, Brain : a journal of neurology.
[9] P. James. An Essay on the Shaking Palsy , 1817, The Medico-Chirurgical Journal and Review.
[10] P. Hoyng,et al. Rate of visual field loss in progressive glaucoma. , 2000, Archives of ophthalmology.
[11] A Heijl,et al. Glaucoma Hemifield Test. Automated visual field evaluation. , 1992, Archives of ophthalmology.
[12] F. Ozturk,et al. The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. , 2007, European journal of ophthalmology.
[13] J. Elias,et al. Levodopa improves spatial contrast sensitivity in Parkinson's disease. , 1993, Archives of neurology.
[14] J. Flanagan,et al. Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma. , 1997, Ophthalmology.
[15] C. Ellis,et al. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study , 1994, Vision Research.
[16] M. Morales i Ballús,et al. Baseline Optical Coherence Tomography Predicts the Development of Glaucomatous Change in Glaucoma Suspects , 2007 .
[17] T. Di Paolo,et al. Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.
[18] M. DomínguezCarmona,et al. [Epidemiology of Parkinson disease]. , 1989, Anales de la Real Academia Nacional de Medicina.
[19] I. Bodis-Wollner. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients , 1990, Trends in Neurosciences.
[20] R. Inzelberg,et al. Retinal nerve fiber layer thinning in Parkinson disease , 2004, Vision Research.
[21] L. Murri,et al. Changes in Pattern Electroretinograms to Equiluminant Red-Green and Blue-Yellow Gratings in Patients with Early Parkinson’s Disease , 2003, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[22] Eliza M. Gordon-Lipkin,et al. Optical coherence tomography and disease subtype in multiple sclerosis , 2007, Neurology.
[23] C. Tanner. Epidemiology of Parkinson’s Disease , 1992, Neurologic Clinics.
[24] A. Lees,et al. Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.
[25] J. Caprioli,et al. Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities. , 2006, Investigative ophthalmology & visual science.
[26] C. Tanner,et al. Epidemiology of Parkinson's disease , 2007, Handbook of Clinical Neurology.
[27] L. Zangwill,et al. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. , 2000, Ophthalmology.
[28] L Maffei,et al. Pattern electroretinograms and visual-evoked potentials in glaucoma and multiple sclerosis. , 1983, American journal of ophthalmology.
[29] O. Appenzeller,et al. Autonomic deficits in Parkinson's syndrome. , 1971, Archives of neurology.
[30] M. C. Leske,et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. , 2003, Archives of ophthalmology.
[31] Gary R Cutter,et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. , 2006, Ophthalmology.
[32] W C Stewart,et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. , 2000, American journal of ophthalmology.
[33] Young H. Kwon,et al. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. , 2001, American journal of ophthalmology.
[34] S. Drance,et al. The rate of progression of scotomas in glaucoma. , 1986, American journal of ophthalmology.
[35] M Tagliati,et al. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. , 1996, Electroencephalography and clinical neurophysiology.
[36] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[37] C. Enroth-Cugell,et al. The contrast sensitivity of retinal ganglion cells of the cat , 1966, The Journal of physiology.
[38] Fatmire Berisha,et al. Retinal abnormalities in early Alzheimer's disease. , 2007, Investigative ophthalmology & visual science.
[39] M. Hankins,et al. Neurobiology of retinal dopamine in relation to degenerative states of the tissue , 1997, Vision Research.
[40] J. Meulstee,et al. Olfactory disturbances in parkinsonism , 1980, Clinical Neurology and Neurosurgery.
[41] Young H. Kwon,et al. Rate and pattern of visual field decline in primary open-angle glaucoma. , 2002, Ophthalmology.
[42] A. Laties,et al. Dopaminergic neurons in the human retina , 1982, The Journal of comparative neurology.
[43] Hansjürgen Bratzke,et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages) , 2002, Journal of Neurology.
[44] M. Ghilardi,et al. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. , 1988, Brain : a journal of neurology.
[45] Georg Lindgren,et al. Reliability parameters in computerized perimetry , 1987 .
[46] M. Ghilardi,et al. The effect of intraocular 6‐hydroxydopamine on retinal processing of primates , 1989, Annals of neurology.
[47] M. Yahr,et al. Measurements of visual evoked potentials in Parkinson's disease. , 1978, Brain : a journal of neurology.
[48] D. Valenti. Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography , 2007, Neurology.
[49] A. Sommer,et al. Estimating progression of visual field loss in glaucoma. , 1997, Ophthalmology.
[50] Y. Çağlar,et al. Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease , 2008, Documenta Ophthalmologica.
[51] L. Maffei,et al. Pattern ERG in the monkey after section of the optic nerve , 1986, Behavioural Brain Research.
[52] B. Bengtsson,et al. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? , 2000, American journal of ophthalmology.